Allarity Therapeutics, Inc.
General ticker "ALLR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $19.6M (TTM average)
Allarity Therapeutics, Inc. follows the US Stock Market performance with the rate: 29.6%.
Estimated limits based on current volatility of 4.3%: low 0.98$, high 1.07$
Factors to consider:
- Total employees count: 9 (+28.6%) as of 2025
- Top business risk factors: Regulatory and compliance, Clinical trial delays, Capital shortage, Labor/talent shortage/retention, Market acceptance
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.67$, 2.82$]
- 2026-12-31 to 2027-12-31 estimated range: [0.39$, 1.81$]
Financial Metrics affecting the ALLR estimates:
- Positive: with PPE of -1.3 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Positive: 49.86 < Shareholder equity ratio, % of 53.83 <= 58.56
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of -15.99 <= 0
Short-term ALLR quotes
Long-term ALLR plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.32MM |
| Operating Expenses | $17.13MM | $27.24MM | $12.93MM |
| Operating Income | $-17.13MM | $-27.24MM | $-12.61MM |
| Non-Operating Income | $5.31MM | $2.35MM | $1.37MM |
| Interest Expense | $0.50MM | $0.65MM | $0.18MM |
| R&D Expense | $7.10MM | $6.10MM | $6.60MM |
| Income(Loss) | $-11.82MM | $-24.90MM | $-11.23MM |
| Taxes | $0.08MM | $-0.38MM | $0.00MM |
| Net Income(Loss)* | $-11.90MM | $-24.52MM | $-11.23MM |
| Stockholders Equity | $-2.75MM | $11.81MM | $9.83MM |
| Assets | $11.86MM | $22.65MM | $18.26MM |
| Operating Cash Flow | $-12.74MM | $-17.35MM | $-14.82MM |
| Capital expenditure | $0.00MM | $0.30MM | $0.01MM |
| Investing Cash Flow | $0.00MM | $-0.30MM | $-0.01MM |
| Financing Cash Flow | $10.99MM | $36.79MM | $10.65MM |
| Earnings Per Share** | $-3.59 | $-15.26 | $-0.78 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.